March, 2022

article thumbnail

The Digital Health Start-up Journey: Series A to scale-up

pharmaphorum

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find. The growth of a start-up after obtaining Series A funding is a transformational phase when scaling up the company becomes critical. The CEO can experience pressure to deliver on the revenue growth goals, whilst still developing their product, growing the team, and implementing core processes for the company.

Hospitals 145
article thumbnail

How to Stay Focused while Studying

Find Your Script

Studying is a skill…one that we may or may not have mastered during many years of education. I know I went through different study methods before settling on one that worked for me during 7 years of higher education. An important part of successful studying is staying focused. If you also want to improve study habits, see this post on the topic.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Enveric taps University of Calgary to study psychedelic therapy in cancer-related distress

Outsourcing Pharma

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.

122
122
article thumbnail

Reason behind the growth of PCD Pharma Franchise in India

Fossil Remedies

It is every entrepreneur’s dream to launch a business that earns a great profit. After all that is something, which everyone aims for. The pharma business has become one of the most popular businesses in the last 20 years. Why? It is because the pharma sector has done remarkably well. Also, it shows signs of good growth in the next few years. If you consider a few data facts, then the pharma sector today around 40+ Billion dollars , and in the next few years, it will cross even 100 Billion dolla

98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. But one key member is often omitted: the patient’s caregiver. With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. Although the caregiver is seen as an extension of the patient and their role is not strictly defined, they are informal members of the front-line care team.

article thumbnail

ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP

Pharma Tutor

ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP. About Author. Meenu Maurya. Email : meenudinesh15@gmail.com. admin. Wed, 03/16/2022 - 15:06. Tags. Articles.

90

More Trending

article thumbnail

Omicron BA.2 variant triggers COVID-19 surge in England

Pharma Times

The sub-variant combines mutations from both Omicron and Delta

72
article thumbnail

Pharma leaders should step up on artificial intelligence: ConcertAI

Outsourcing Pharma

An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking.

109
109
article thumbnail

Exosomes: A Deeper Look into Service Providers Market

Roots Analysis

Over the years, applications of exosomes in therapeutics have undergone an evolutionary change, in terms of cost of research, technology used, and duration of the study. Moreover, various startups and small firms have entered into collaborations in order to advance their innovations and offer specialized research expertise, services and technologies.

article thumbnail

Benefits of Adopting Multichannel Marketing in Pharma

Pharma Mirror

It all started in March 2020 and it is now Jan 2022. We still can’t declare the COVID pandemic as “finished”. How has the pandemic impacted the field marketing activity of Pharma companies? What should the industry do to prepare for what will definitely be a new world, post-COVID? There were many analysts who, even before the pandemic, were saying that the role of Medical Representatives will reduce.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

A REVIEW ON CLINICAL DATA MANAGEMENT : CURRENT STATUS IN CLINICAL RESEARCH

Pharma Tutor

A REVIEW ON CLINICAL DATA MANAGEMENT : CURRENT STATUS IN CLINICAL RESEARCH. About Authors. MANISHA KOTADIYA*, JAYDEEP SAVALIYA. *Shree Swaminarayan Sanskar Collage of Pharmacy Zundal, Gandhinagar, Gujarat, Email Id: manishakotadiya3@gmail.com, FTF Pharma Pvt. Ltd. – Ahmedabad, Email ID: jaydeepsavaliya27@gmail.com. admin. Sat, 03/26/2022 - 17:13. Tags.

59
article thumbnail

Virtual and augmented reality: Bringing the future to pharma manufacturing

pharmaphorum

Virtual and augmented reality tools have reached a level of maturity to be utilised across various industries. In this article, Ben Hargreaves asks whether there is particular potential for the technologies to revolutionise staff training and reduce costs in pharma manufacturing. Virtual reality (VR) and augmented reality (AR) have spent a lot of time in the headlines recently.

article thumbnail

UK’s first digital health training programme for all NHS frontline staff

Pharma Times

The platform to build a digital-ready frontline workforce will be available to all NHS and social care staff

71
article thumbnail

Innovative Purdue research leads to FDA-approved prostate cancer treatment

Outsourcing Pharma

A renowned university researcher explains the path that laid the foundation and what the novel diagnostic and treatment means for prostate cancer patients.

FDA 105
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

My Rewarding Path as a Pharmacy Technician: A Reflection on Career Growth and Opportunity

McCreadie Group

April 2022 | Mindy Suttlemyre, BS, PhT I was honored to present “Off the Beaten Path: Exploring Opportunities for Technicians within IDS Pharmacy” at McCreadie Group’s 2021 Research Pharmacy Summit. When asked to be a speaker, I was working at The University of Utah/Huntsman Cancer Hospital IDS as the Lead Pharmacy Technician and was eager to. The post My Rewarding Path as a Pharmacy Technician: A Reflection on Career Growth and Opportunity appeared first on McCreadie Group Blog.

article thumbnail

Pipelinepharma marketplace records quadruple growth over a single year

Pharma Mirror

The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. Compared to 19 600 products at the start of 2021, the product offering has increased fourfold over a single year. As a response to increasing demand, Pipelinepharma will introduce biosimilar drugs into a separate category.

Dosage 52
article thumbnail

Embracing Medical Career Transitions

Board Vitals - Pharmacist

Our lives are often divided into chapters, delineated by specific transition points. Much like blood flowing through our circulatory system, the trajectory of our lives can be turbulent at times while laminer at others. It can advance and progress, but can also be met with opposition and obstruction. It is in those watershed moments when we recall a notable difference, a growth.

article thumbnail

Amazon, Teladoc to deliver doctor consultations via Alexa

pharmaphorum

Amazon’s encroachment into healthcare advanced a little further this week when the online giant launched a doctor consultation service delivered via its Alexa voice assistant, with the help of telehealth player Teladoc. Users of the service will be able to request non-urgent medical care around the clock, simply by telling Alexa via their Amazon Echo device that they want to speak to a doctor.

Insurance 135
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

NHS mental health referrals has reached record high

Pharma Times

COVID-19 has highlighted another significant widespread problem – the mental health pandemic

65
article thumbnail

AstraZeneca, Merck breast cancer treatment lands FDA approval

Outsourcing Pharma

The agency has approved Lynparza for use in the US as an adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.

FDA 102
article thumbnail

Give it a go! (Kerry’s Ice Hockey)

NF2 BioSolutions

– Everyone’s journey with NF2 is different. No 2 cases are the same. The biggest problem we face is the ‘unknown’ and never knowing what’s around the corner for us. After being diagnosed and going through a whirlwind of emotions. I decided to start looking into new activities/hobbies to try, looking for something physical so that I could try and keep my body strong and active. – – Ice hockey is something that I’d always wanted to try, but was never

52
article thumbnail

Beyond Next Best Action: Achieving Omnichannel That Works

Pharma Marketing Network

Pharmaceutical companies have been successful for decades with a siloed marketing strategy. Rep-led field engagement, television advertising, and digital marketing have all been planned, executed, and measured separately, but customer expectations are changing fast. With the pandemic and the shift to mobile devices, customers are demanding more convenient and seamless ways to interact with pharma companies.

article thumbnail

New liquid filling machine for sterile ophthalmic products – Oftalmica by Romaco Macofar

Pharma Mirror

Karlsruhe/Germany, Romaco Macofar’s Oftalmica was specially developed for aseptic filling of sterile eye drops, nasal sprays and injectables. Meeting all GMP requirements for safe processing of highly viscous, oily and foaming liquids, the machine additionally offers fast format changes and short cleaning times. The Oftalmica is Romaco Macofar’s latest technology for aseptic filling of sterile eye drops.

52
article thumbnail

Roche starts new four-year trial of Alzheimer’s drug gantenerumab

pharmaphorum

With prospects of an early, accelerated approval for Roche’s Alzheimer’s disease candidate gantenerumab looking diminished, the drugmaker has launched a new four-year trial in the hope of building its case for the drug. The new placebo-controlled SKYLINE study will enrol 1,250 people aged 60 to 80 with the earliest biological signs of Alzheimer’s – in other words signs of amyloid accumulation in the central nervous system – but no cognitive impairment.

Hospitals 135
article thumbnail

Doctors and nurses produce roadmap to future-proof healthcare

Pharma Times

Report uses input from healthcare professionals to highlight training and support needs, while also warning about departures

61
article thumbnail

The right tech can fill gap between lab scientist and data: ACD/Labs

Outsourcing Pharma

An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.

102
102
article thumbnail

Metabolomics: An Emerging yet Powerful Tool in Clinical Research and Development

Roots Analysis

Scientific fields involved in high throughput measurement of biological molecules are referred with the suffix- omics including, transcriptomics, genomics, proteomics and metabolomics. Genomics is the study of genetic material within a cell, and transcriptomics is the study of gene activity in different cells. Likewise, metabolomics refers to the study of byproducts of metabolism.

article thumbnail

Ep. 20: Cultural Competence For Global Marketing

Pharma Marketing Network

Tune in to this episode of the Pharma marketing Podcast, with our guest Wendy Pease, President of Rapport International and the author of The Language of Global Marketing for a conversation on why pharma should be thinking global from the start, addressing how to keep a consistent brand globally, and the many things that need to be considered when curating your global market.

52
article thumbnail

Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Pivotal Phase 3 Atopic Dermatitis Studies

Pharma Mirror

BARCELONA, Spain, More than 50 percent of patients with moderate-to-severe atopic dermatitis (AD) experienced at least 75 percent reduction in disease severity (EASI-75*) at 16 weeks when receiving lebrikizumab monotherapy in the ADvocate program, Almirall S.A. (BME: ALM) announced today at the American Academy of Dermatology (AAD) Annual Meeting. Lebrikizumab, an investigational IL-13 inhibitor, also led to clinically meaningful improvements in itch and other important patient-reported outcomes

52
article thumbnail

Pharma’s ambition in connected health not yet matched by execution

pharmaphorum

Four out of five biopharma companies think that the market opportunity for connected health products exceeds their traditional drug business, but adoption remains low, with only 20% of use cases at present going beyond proof of concept. That’s one of the conclusions of a new study by Capgemini, which suggests that the number of approved connected health offerings – digital health products and services including wearables, digital therapeutics and software-as-a-medical-device (SaMD) – will

124
124
article thumbnail

NHS fast-tracks new targeted drug for rare lung cancer

Pharma Times

Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed by surgery

59
article thumbnail

Oracle: How can clinical trials better fill the patient inclusivity gap?

Outsourcing Pharma

While strides have been made recruiting more representative patient populations, more can and should be done, according to an Oracle Health Sciences leader.

101
101
article thumbnail

New 2022 Rates Position CMS’ Chronic Care Programs Are Ripe for Increased Revenue, Improved Outcomes

PharmD Live

If you’ve implemented chronic care management (CCM) or remote physiologic monitoring (RPM, a.k.a. remote patient monitoring) in your practice, you know that they generate new streams of revenue while allocating more time to take better care of your patients—with potentially life-saving results. In fact, Medicare is so confident that these programs will pay off that it has dramatically increased CCM overall reimbursement rates for 2022.

52